Skip to content
value.today

4C Medical Technologies, Inc.

Formerly 4C Medical, Inc.

Total raised
$64 M
4 rounds on record
Latest round
$35 M
Nov 2021
First round on record
Apr 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of 4C Medical Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$72 MIssued in a merger or acquisition$50 to $250 million

4C Medical Technologies, Inc.: Private sale, Mar 2026

Investors in this round

80 investors had bought by the notice of Mar 31, 2026: 80 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$72 M of $166 M offered; $94 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$9,295,063
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harley Handegard · Executive Officer
  • Katherine Kumar · Executive Officer
  • Saravana Kumar · Executive Officer, Director
  • Buzz Benson · Director
  • Jeffrey Chambers · Director
  • Jonathan Chen · Director
  • Rhonda Robb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Sandler & Co. (CRD 665) · broker-dealer Piper Sandler & Co. (CRD 665) · Minneapolis, MinnesotaSold in all US states

Remarks in the notice

  • On fees: “Assumes all closings are completed.”
  • On the amounts: “13(a) and (b) include the conversion of notes having an outstanding balance of $34,608,151. Excludes sales made to certain non-U.S. investors in reliance on Regulation S.”

Signed by Harley Handegard, Chief Financial Officer. Newest notice filed Mar 31, 2026. Read the notice at the SEC.

equity, optionsSEC
Mar 2025$72 MIssued in a merger or acquisition$50 to $250 million

4C Medical Technologies, Inc.: Private sale, Mar 2025

Investors in this round

80 investors had bought by the notice of Mar 19, 2025: 80 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$72 M of $166 M offered; $94 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$9,295,063
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harley Handegard · Executive Officer
  • Katherine Kumar · Executive Officer
  • Saravana Kumar · Executive Officer, Director
  • Buzz Benson · Director
  • Jeffrey Chambers · Director
  • Jonathan Chen · Director
  • Rhonda Robb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Sandler & Co. (CRD 665) · broker-dealer Piper Sandler & Co. (CRD 665) · Minneapolis, MinnesotaSold in all US states

Remarks in the notice

  • On fees: “Assumes all closings are completed.”
  • On the amounts: “13(a) and (b) include the conversion of notes having an outstanding balance of $34,608,151. Excludes sales made to certain non-U.S. investors in reliance on Regulation S.”

Signed by Harley Handegard, Chief Financial Officer. Newest notice filed Mar 19, 2025. Read the notice at the SEC.

equity, optionsSEC
Nov 2021$35 MNo. 4$10 to $50 million

4C Medical Technologies, Inc.: Raise no. 4, Nov 2021

Investors in this round

53 investors had bought by the notice of Nov 16, 2021: 53 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $61 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Katherine W. Kumar · Executive Officer
  • Saravana Kumar · Executive Officer, Director
  • Scott W. Youngstrom · Executive Officer
  • Buzz W. Benson · Director
  • Jeffrey W. Chambers · Director
  • Jonathan W. Chen · Director
  • Rhonda W. Robb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount and Total Amount Sold includes the exchange of promissory notes having an outstanding balance of $15,611,201.”

Signed by Scott Youngstrom, Chief Financial Officer. Newest notice filed Nov 16, 2021. Read the notice at the SEC.

equitySEC
Sep 2019$8 MNo. 3$2 to $10 million

4C Medical Technologies, Inc.: Raise no. 3, Sep 2019

Investors in this round

45 investors had bought by the notice of Oct 2, 2019: 45 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $20 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • James E. Flaherty · Executive Officer
  • Jeffrey W. Chambers · Executive Officer, Director, Promoter
  • Katherine J. Kumar · Executive Officer
  • Robert J. Thatcher · Executive Officer, Director
  • Saravana J. Kumar · Executive Officer
  • Buzz J. Benson · Director
  • Jonathan J. Chen · Director
  • William J. Hoffman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Flaherty, Secretary. Newest notice filed Oct 2, 2019. Read the notice at the SEC.

equitySEC
Sep 2018$17 MNo. 2$10 to $50 million

4C Medical Technologies, Inc.: Raise no. 2, Sep 2018

Investors in this round

23 investors had bought by the notice of Sep 19, 2018: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $25 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James E. Flaherty · Executive Officer
  • Jeffrey W. Chambers · Executive Officer, Director, Promoter
  • Katherine J. Kumar · Executive Officer
  • Robert J. Thatcher · Executive Officer, Director
  • Saravana J. Kumar · Executive Officer
  • Jonathan J. Chen · Director
  • William J. Hoffman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert J. Thatcher, Chief Executive Officer. Newest notice filed Sep 19, 2018. Read the notice at the SEC.

equitySEC
Apr 2018$3 MNo. 1$2 to $10 million

4C Medical Technologies, Inc.: Raise no. 1, Apr 2018

Investors in this round

29 investors had bought by the notice of May 17, 2018: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $15 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • James E. Flaherty · Executive Officer
  • Jeffrey W. Chambers · Executive Officer, Director, Promoter
  • Katherine J. Kumar · Executive Officer
  • Robert J. Thatcher · Executive Officer, Director
  • Saravana J. Kumar · Executive Officer
  • William J. Hoffman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert J. Thatcher, Chief Executive Officer. Newest notice filed May 17, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • 4C Medical Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2026).

    SEC Form D · Mar 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Mar 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of 4C Medical Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by 4C Medical Technologies, Inc.
NameRoleNamed in
Harley HandegardExecutive officerMar 2026
Katherine KumarExecutive officerMar 2026
Saravana KumarExecutive officerMar 2026
Katherine W. KumarExecutive officerNov 2021
Scott W. YoungstromExecutive officerNov 2021
James E. FlahertyExecutive officerOct 2019
Jeffrey W. ChambersExecutive officerOct 2019
Katherine J. KumarExecutive officerOct 2019
Robert J. ThatcherExecutive officerOct 2019
Saravana J. KumarExecutive officerOct 2019
Buzz BensonDirectorMar 2026
Jeffrey ChambersDirectorMar 2026
Jonathan ChenDirectorMar 2026
Rhonda RobbDirectorMar 2026
Saravana KumarDirectorMar 2026
Buzz W. BensonDirectorNov 2021
Jeffrey W. ChambersDirectorNov 2021
Jonathan W. ChenDirectorNov 2021
Rhonda W. RobbDirectorNov 2021
Buzz J. BensonDirectorOct 2019
Jonathan J. ChenDirectorOct 2019
Robert J. ThatcherDirectorOct 2019
William J. HoffmanDirectorOct 2019
Jeffrey W. ChambersPromoterOct 2019